Salesforce, Inc.
Is there value inside this enterprise that the company is not currently capturing?
Filings through Jul 31, 2026 · Market data as of Sep 16, 2026
WE MODEL THE ENTERPRISE.™
01Executive summary
Salesforce, Inc. enters the engine with $43.9B of trailing revenue, $9.9B of GAAP-derived EBITDA and a $234.1B enterprise value. Token Clear detected 8 value pathways from the company's own filings, led by Margin Recovery Program, Treasury Optimization and IP Licensing & Platform Monetization. Counted pathways model $572.8M–$1.5B of recurring annual economics, or $13.5B–$36.2B at today's multiple (5.8%–15.5% of current enterprise value) — against a 1% Thesis of $2.3B.
- Trades at 23.6× EV / EBITDA versus a live median of 18.6× across 5 peers — a 27% premium.
- $66.3B of contracted backlog covers 1.5× of annual revenue.
- Revenue grew 9.6% in the latest fiscal year.
02Current enterprise state
| Fact | Value | Class | Period | Source |
|---|---|---|---|---|
| Revenue (TTM) | $43.9B | CALCULATED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Revenue growth (latest FY) | 9.6% | CALCULATED | Jan 31, 2026 | FY 2026-01-31 revenue ÷ FY 2025-01-31 revenue − 1 |
| EBITDA (TTM, GAAP-derived) | $9.9B | CALCULATED | Jul 31, 2026 | Operating income + D&A |
| EBITDA margin (TTM) | 22.6% | CALCULATED | Jul 31, 2026 | EBITDA ÷ revenue |
| EBITDA margin FY2025 | 21.7% | CALCULATED | Jan 31, 2025 | (Operating income + D&A) ÷ revenue, prior fiscal year |
| Net income (TTM) | $9.7B | CALCULATED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Operating cash flow (TTM) | $15.8B | CALCULATED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Capital expenditures (TTM) | $596.0M | CALCULATED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Free cash flow (TTM) | $15.2B | CALCULATED | Jul 31, 2026 | Operating cash flow − capex |
| Cash & short-term investments | $11.4B | CALCULATED | Jul 31, 2026 | Cash + short-term investments |
| Total debt | $39.3B | REPORTED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Shareholders' equity | $38.4B | REPORTED | Jul 31, 2026 | 10-Q · filed 2026-08-27 |
| Shares outstanding | 823.0M | REPORTED | Aug 20, 2026 | 10-Q · filed 2026-08-27 |
| Share price | $250.54 | REPORTED | Sep 16, 2026 | Yahoo Finance · NYSE |
| Market capitalization | $206.2B | CALCULATED | Sep 16, 2026 | Share price × shares outstanding |
| Enterprise value | $234.1B | CALCULATED | Sep 16, 2026 | Market cap + total debt − cash & short-term investments |
| EV / EBITDA | 23.6× | CALCULATED | Sep 16, 2026 | Enterprise value ÷ EBITDA (TTM) |
03Evidence quality
04Value pathways
Ranked by deterministic Token Clear score. Each pathway lists the evidence that triggered it, the assumptions that size it, and what stands in its way.
EBITDA margin of 22.6% trails the live peer median of 39.1%. Closing part of the 3.0% gap on $43.9B of revenue is a direct EBITDA lever.
Salesforce, Inc. holds $11.4B of cash and short-term investments against an operating reserve of $4.4B (10% of TTM revenue). A tiered treasury policy on the $7.0B above reserve can raise yield without reducing liquidity coverage.
Salesforce, Inc. spends $6.4B a year on R&D (14.5% of revenue). Licensing, API and white-label models can earn a return on IP that today supports only first-party products.
Stock-based compensation is $3.7B a year (8.3% of revenue). Participation structures that align employees with measured enterprise outcomes can deliver the same retention with less dilution.
Proprietary transaction, usage and customer data across $43.9B of revenue can be packaged into permissioned benchmarking, risk and AI products for customers and partners.
Free cash flow yield is 7.3% ($15.2B on a $206.2B market cap) versus a 0.8% implied cost of debt and 10.4% ROIC (peer median 23.5%). At this yield, repurchases, deleveraging and acquisitions compete for the same dollar; Token Clear ranks each use of cash on modeled per-share value and risk rather than defaulting to one answer.
Remaining performance obligations of $66.3B cover 1.5× of annual revenue. Contracted backlog of this quality can support revenue-participation or receivables-backed capital at a lower cost than unsecured funding.
A board-approved policy could allocate 0.5%–2.0% of the $7.0B excess liquidity to digital-asset reserves tied to a defined strategic purpose. Returns are price-dependent and are not modeled.
05Financial scenarios
| Scenario | Pathway EBITDA | Modeled EBITDA | EV at today's 23.6× | vs. today | EV at peer 18.6× (re-rating) |
|---|---|---|---|---|---|
| Today (reported) | $0.00 | $9.9B | $234.1B | 0.0% | $184.4B |
| Conservative | $572.8M | $10.5B | $247.6B | 5.8% | $195.0B |
| Base | $1.1B | $11.0B | $258.9B | 10.6% | $203.9B |
| Strategic | $1.5B | $11.5B | $270.3B | 15.5% | $212.8B |
Scenario columns apply the low, midpoint and high end of every counted pathway range. The peer column isolates a market re-rating and is shown for sensitivity only.
06Multiple Intelligence™
| Driver | Salesforce, Inc. | Peer median | Read |
|---|---|---|---|
| Revenue growth | 9.6% | 17.3% | behind |
| EBITDA margin | 22.6% | 39.1% | behind |
| FCF conversion | 152.5% | 34.5% | ahead |
| Return on invested capital | 10.4% | 23.5% | behind |
| Net leverage | 2.8× | -0.1× | behind |
| Capex intensity | 1.4% | 29.7% | ahead |
| Stock comp / revenue | 8.3% | 7.1% | behind |
Peer set (5 valid of 5): MSFT 18.6× · GOOGL 23.4× · ORCL 15.5× · ADBE 10.0× · NOW 53.6×.
07The 1% Thesis™ — validated bottom-up
08Recommended sequence & 90-day proof of value
- • Treasury Optimization
- • Margin Recovery Program
- • IP Licensing & Platform Monetization
- • Employee Ownership & Retention Program
- • Data & AI Products
- • Capital Allocation Engine
- • Contracted Revenue Financing (RPO)
- • Reserve Diversification Policy (Digital Assets)
| Days 1–15 | Validate | Confirm reported facts, peer set and every ASSUMPTION with Salesforce, Inc. finance leadership; close DATA REQUIRED gaps from primary filings. |
| Days 16–45 | Design | Detailed design for NOW pathways: Treasury Optimization. Counsel review of regulatory blockers. |
| Days 46–75 | Approve & activate | Human approval gate per pathway; activate approved pathways with defined owners and baselines. |
| Days 76–90 | Measure | Baseline vs. target vs. actual on the first measurable metrics; decide on NEXT pathways and a platform engagement. |
09Risks & dependencies
- Data rights, privacy and customer consent.
- Accounting, custody and board risk-appetite approval required.
10Methodology & disclosures
Evidence classes. REPORTED taken from SEC XBRL filings or delayed market data · CALCULATED deterministic derivation with formula · BENCHMARK live peer comparable · ASSUMPTION explicit, challengeable input · SCENARIO output of stated assumptions.
Calculations. Trailing-twelve-month figures are fiscal year + current year-to-date − prior year-to-date. EBITDA is operating income plus depreciation and amortization (GAAP-derived, excluding non-GAAP adjustments). Enterprise value is market capitalization plus total debt less cash and short-term investments, excluding leases, minority interest and preferred equity. Non-USD filers are converted at spot. Recurring pathway economics are valued at today's multiple; overlapping pathways are counted once and contingent pathways are excluded.
Governance. AI does not perform or override valuation arithmetic. Scoring configuration is confidential and server-side. No pathway proceeds without human approval.
Disclosure. This study provides enterprise-value intelligence, scenario modeling and strategic analysis. Illustrative scenarios are not forecasts, guarantees, investment recommendations or assurances of market valuation. Market prices and valuation multiples are determined by investors and market conditions. Certain strategies require legal, tax, accounting, regulatory and other professional review before implementation.